Literature DB >> 28233159

The effects of co-administration of pregabalin and vitamin E on neuropathic pain induced by partial sciatic nerve ligation in male rats.

Manzumeh-Shamsi Meymandi1,2, Gholamreza Sepehri3,4, Mona Abdolsamadi2, Mohammad Shaabani1, Gioia Heravi2, Omid Yazdanpanah2, Mohammadmehdi-Moeini Aghtaei5.   

Abstract

OBJECTIVE: This study was performed to evaluate the effect of pregabalin co-administration with vitamin E in Partial Sciatic Nerve Ligation (PSNL)-induced neuropathic pain in rats.
METHODS: Male Wistar rats were randomly allocated as control, sham, and PSNL groups (n = 8). PSNL was induced by tight ligation of the sciatic nerve with a copper wire. On day 14th, the PSNL and sham operated rats received either pregabalin (1, 3, and 30 mg/kg), vitamin E (100 and 200 mg/kg), or their combination intraperitoneally. An antinociceptive effect was evaluated as latency times and Maximum possible Effect Percent (%MPE) using tail-flick test. Locomotor activity was evaluated by open-field test before PSNL surgery and then twice at the 14th days (before and after drug injection). Ligated nerves were removed on the 28th days after surgery for histological examinations.
RESULTS: The time course of latency times and %MPE showed significant decrease in PSNL but not in sham and control groups. Pregabalin (3 and 30 mg/kg) and vitamin E (100 and 200 mg/kg) caused significant increases in latency time in PSNL (but not sham) group compared to control group. Vitamin E 200 mg/kg increased significantly %MPE in PSNL group compared to sham group. In addition, the %MPE following combination treatment of pregabalin (30 mg/kg) and vitamin E (100 mg/kg) was significantly higher than both vitamin E and control group. Also combination of pregabalin with 100 mg/kg of vitamin E reversed Wallerian degeneration of sciatic nerve and the inflammatory responses to almost similar to sham group. Pregabalin and vitamin E did not affect locomotor activity.
CONCLUSION: Our results showed antinociceptive effects of both vitamin E and pregabalin alone or in combination in PSNL rats and also neuroprotective properties without affecting locomotor activity.

Entities:  

Keywords:  Drug combination; Histopathology; Neuropathic pain; Partial sciatic nerve ligation; Pregabalin; Vitamin E

Mesh:

Substances:

Year:  2017        PMID: 28233159     DOI: 10.1007/s10787-017-0325-4

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  57 in total

1.  Drugs for neuropathic pain.

Authors:  Eija Kalso; D J Aldington; R A Moore
Journal:  BMJ       Date:  2013-12-19

2.  Effects of safranal, a constituent of saffron, and vitamin E on nerve functions and histopathology following crush injury of sciatic nerve in rats.

Authors:  Esmaeal Tamaddonfard; Amir Abbas Farshid; Shirin Maroufi; Sharare Kazemi-Shojaei; Amir Erfanparast; Siamak Asri-Rezaei; Mina Taati; Milad Dabbaghi; Mona Escort
Journal:  Phytomedicine       Date:  2013-12-04       Impact factor: 5.340

Review 3.  Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.

Authors:  Robert H Dworkin; Alec B O'Connor; Joseph Audette; Ralf Baron; Geoffrey K Gourlay; Maija L Haanpää; Joel L Kent; Elliot J Krane; Alyssa A Lebel; Robert M Levy; Sean C Mackey; John Mayer; Christine Miaskowski; Srinivasa N Raja; Andrew S C Rice; Kenneth E Schmader; Brett Stacey; Steven Stanos; Rolf-Detlef Treede; Dennis C Turk; Gary A Walco; Christopher D Wells
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

4.  Antinociceptive and hypnotic activities of pregabalin in a neuropathic pain-like model in mice.

Authors:  Tian-Xiao Wang; Dou Yin; Wei Guo; Yuan-Yuan Liu; Ya-Dong Li; Wei-Min Qu; Wu-Jian Han; Zong-Yuan Hong; Zhi-Li Huang
Journal:  Pharmacol Biochem Behav       Date:  2015-05-16       Impact factor: 3.533

Review 5.  Anti-inflammatory properties of alpha- and gamma-tocopherol.

Authors:  Elke Reiter; Qing Jiang; Stephan Christen
Journal:  Mol Aspects Med       Date:  2007-01-11

6.  Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial.

Authors:  Samuel Oliveira de Afonseca; Felipe Melo Cruz; Daniel de Iracema Gomes Cubero; Andrea Thaumaturgo Lera; Fernanda Schindler; Marcia Okawara; Luiz Fernando de Souza; Nataly Pimentel Rodrigues; Auro del Giglio
Journal:  Sao Paulo Med J       Date:  2013       Impact factor: 1.044

7.  Effects of pregabalin on the nociceptive, emotional and cognitive manifestations of neuropathic pain in mice.

Authors:  C La Porta; I M Lara-Mayorga; R Negrete; R Maldonado
Journal:  Eur J Pain       Date:  2016-03-31       Impact factor: 3.931

Review 8.  [Lipid peroxidation and mechanism of antioxidant effect of vitamin E].

Authors:  V V Chudinova; S M Alekseev; E I Zakharova; R P Evstigneeva
Journal:  Bioorg Khim       Date:  1994-10

9.  Pregabalin as a neuroprotector after spinal cord injury in rats: biochemical analysis and effect on glial cells.

Authors:  Kee-Yong Ha; Eugene Carragee; Ivan Cheng; Soon-Eok Kwon; Young-Hoon Kim
Journal:  J Korean Med Sci       Date:  2011-02-25       Impact factor: 2.153

10.  Antinociceptive effects of intraperitoneal and intrathecal vitamin e in the rat formalin test.

Authors:  Myoung Joong Kim; Boo Hwi Hong; En Ji Zhang; Young Kwon Ko; Won Hyung Lee
Journal:  Korean J Pain       Date:  2012-10-04
View more
  4 in total

Review 1.  The peripheral corticotropin-releasing factor (CRF)-induced analgesic effect on somatic pain sensitivity in conscious rats: involving CRF, opioid and glucocorticoid receptors.

Authors:  Natalia I Yarushkina; Ludmila P Filaretova
Journal:  Inflammopharmacology       Date:  2018-02-05       Impact factor: 4.473

2.  Comparative effect of photobiomodulation associated with dexamethasone after sciatic nerve injury model.

Authors:  Luana Gabriel de Souza; Alexandre Márcio Marcolino; Heloyse Uliam Kuriki; Elaine Cristina Dalazen Gonçalves; Marisa de Cássia Registro Fonseca; Rafael Inácio Barbosa
Journal:  Lasers Med Sci       Date:  2018-04-02       Impact factor: 3.161

3.  Angiotensin II type 1 receptor blocker losartan attenuates locomotor, anxiety-like behavior, and passive avoidance learning deficits in a sub-chronic stress model.

Authors:  Hoda Ranjbar; Iraj Aghaei; Mahmood Moosazadeh; Mohammad Shabani
Journal:  Iran J Basic Med Sci       Date:  2018-08       Impact factor: 2.699

4.  Combined Treatment of Adipose Derived-Mesenchymal Stem Cells and Pregabalin Is Superior to Monotherapy for the Treatment of Neuropathic Pain in Rats.

Authors:  Shimaa Mohammad Yousof; Doaa Attia ElSayed; Amani A El-Baz; Hanaa S Sallam; Faten Abbas
Journal:  Stem Cells Int       Date:  2021-02-15       Impact factor: 5.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.